Total Payments
$553.00
2023 Payments
$30.52
Companies
12
Transactions
31
Medicare Patients
4,432
Medicare Billing
$354,390
Payment Breakdown by Category
Food & Beverage$552.17 (99.8%)
Education$0.83 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $552.17 | 30 | 99.8% |
| Education | $0.83 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $180.48 | 8 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $68.36 | 5 | $0 (2021) |
| Shire North American Group Inc | $65.44 | 5 | $0 (2019) |
| ABBVIE INC. | $64.53 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $40.00 | 3 | $0 (2019) |
| Johnson & Johnson Vision Care, Inc. | $37.56 | 2 | $0 (2017) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $27.42 | 2 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $23.95 | 1 | $0 (2017) |
| GENZYME CORPORATION | $15.92 | 1 | $0 (2023) |
| CooperVision Inc. | $14.60 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.52 | 2 | GENZYME CORPORATION ($15.92) |
| 2022 | $64.53 | 1 | ABBVIE INC. ($64.53) |
| 2021 | $11.88 | 1 | SUN PHARMACEUTICAL INDUSTRIES INC. ($11.88) |
| 2020 | $12.62 | 1 | Sun Pharmaceutical Industries Inc. ($12.62) |
| 2019 | $263.67 | 15 | Allergan Inc. ($149.77) |
| 2018 | $63.68 | 5 | Shire North American Group Inc ($22.58) |
| 2017 | $106.10 | 6 | Johnson & Johnson Vision Care, Inc. ($37.56) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Genetic Disease | ||||||
| 02/01/2023 | CooperVision Inc. | MiSight Contact Lens (Device) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Devices | ||||||
| 05/04/2022 | ABBVIE INC. | VUITY (Drug) | Food and Beverage | In-kind items and services | $64.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/07/2021 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug), BromSite, Xelpros | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Ophthalmology | ||||||
| 03/04/2020 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug), CEQUA | Food and Beverage | Cash or cash equivalent | $12.62 | General |
| Category: Ophthalmology | ||||||
| 12/24/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug), ZYLET, BESIVANCE | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/20/2019 | Allergan Inc. | ALPHAGAN P (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/18/2019 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $13.95 | General |
| Category: Ophthalmology | ||||||
| 12/04/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $12.50 | General |
| 11/27/2019 | Allergan Inc. | ALPHAGAN P (Drug) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/20/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/06/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 10/23/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/16/2019 | Sun Pharmaceutical Industries Inc. | XELPROS (Drug), CEQUA | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: Ophthalmology | ||||||
| 10/07/2019 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: DRY EYE | ||||||
| 09/25/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $12.50 | General |
| 06/19/2019 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: DRY EYE | ||||||
| 04/16/2019 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 03/27/2019 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $112.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/06/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: OPTHALMICS | ||||||
| 12/19/2018 | Sun Pharmaceutical Industries Inc. | BromSite (bromfenac ophthalmic solution) 0.075% (Drug), XELPROS (latanoprost ophthalmic emulsion) 0.005% | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Ophthalmology | ||||||
| 12/06/2018 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/15/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: OPTHALMICS | ||||||
| 04/25/2018 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: OPTHALMICS | ||||||
| 02/13/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,114 | 1,310 | $311,253 | $88,752 |
| 2022 | 12 | 1,156 | 1,349 | $315,128 | $93,102 |
| 2021 | 12 | 1,183 | 1,401 | $350,299 | $99,448 |
| 2020 | 12 | 979 | 1,122 | $224,625 | $73,088 |
Total Patients
4,432
Total Services
5,182
Medicare Billing
$354,390
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 326 | 357 | $57,120 | $32,633 | 57.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 222 | 361 | $39,710 | $24,750 | 62.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 103 | 103 | $19,055 | $11,869 | 62.3% |
| 92250 | Photography of the retina | Office | 2023 | 158 | 161 | $16,100 | $4,524 | 28.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 81 | 83 | $15,770 | $4,014 | 25.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 29 | 39 | $135,673 | $3,514 | 2.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $3,900 | $2,510 | 64.4% |
| 92134 | Imaging of retina | Office | 2023 | 63 | 72 | $10,800 | $2,197 | 20.3% |
| 92133 | Imaging of optic nerve | Office | 2023 | 75 | 77 | $11,550 | $1,883 | 16.3% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 15 | 15 | $1,275 | $756.47 | 59.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 12 | 12 | $300.00 | $100.32 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 323 | 369 | $59,040 | $35,010 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 207 | 325 | $35,750 | $21,685 | 60.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 128 | 128 | $23,680 | $15,153 | 64.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 97 | 102 | $19,380 | $5,195 | 26.8% |
| 92250 | Photography of the retina | Office | 2022 | 164 | 167 | $16,700 | $4,971 | 29.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2022 | 29 | 38 | $132,194 | $3,471 | 2.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 94 | 98 | $14,700 | $2,727 | 18.6% |
| 92134 | Imaging of retina | Office | 2022 | 50 | 57 | $8,550 | $1,953 | 22.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $2,730 | $1,884 | 69.0% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 11 | 11 | $935.00 | $568.58 | 60.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 14 | 14 | $994.00 | $310.51 | 31.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2022 | 18 | 19 | $475.00 | $172.81 | 36.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 329 | 376 | $59,740 | $36,898 | 61.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 205 | 343 | $37,120 | $24,817 | 66.9% |
About Dr. Richard Wise, M.D
Dr. Richard Wise, M.D is a Ophthalmology healthcare provider based in Galloway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619971520.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Wise, M.D has received a total of $553.00 in payments from pharmaceutical and medical device companies, with $30.52 received in 2023. These payments were reported across 31 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($552.17).
As a Medicare-enrolled provider, Wise has provided services to 4,432 Medicare beneficiaries, totaling 5,182 services with total Medicare billing of $354,390. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Galloway, NJ
- Active Since 06/08/2005
- Last Updated 01/03/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619971520
Products in Payments
- LUMIGAN (Drug) $139.89
- XIIDRA (Drug) $79.35
- VUITY (Drug) $64.53
- Acuvue (Device) $37.56
- XELPROS (Drug) $28.59
- VYZULTA (Drug) $27.42
- RESTASIS (Drug) $26.28
- LOTEMAX GEL (Drug) $23.95
- FABRAZYME (Biological) $15.92
- MiSight Contact Lens (Device) $14.60
- ALPHAGAN P (Drug) $14.31
- CEQUA (Drug) $13.95
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $13.94
- Cequa (Drug) $11.88
- (820) Cholbam (Drug) $0.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.